-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Hebei Guangxiang Secures Its First Patent Certificate
Category:
TIME：2019-12-03
【SUMMARY】
Recently, good news came from the National Intellectual Property Administration: the technological innovation achievement “Continuous Cooling Crystallization Apparatus for Sodium Theophylline Salt,” submitted by the Group Company and Hebei Guangxiang Pharmaceutical Co., Ltd., has been granted a utility model patent certificate. According to reports, this is the first patent certificate obtained by Hebei Guangxiang Pharmaceutical.
Recently, good news came from the National Intellectual Property Administration: the innovative technological achievement of the “Continuous Cooling Crystallization Apparatus for Sodium Theophylline Salt,” submitted by the Group Company and Hebei Guangxiang Pharmaceutical Co., Ltd., has been granted a utility model patent certificate. According to reports, this is the first patent certificate obtained by Hebei Guangxiang Pharmaceutical.
According to the R&D team, this project employs innovative and cutting-edge technologies to design a utility-model device that significantly enhances the production efficiency of sodium theophylline, features a compact layout to minimize land use, and produces crystals with larger, more uniform particle sizes. The process control system is implemented on a DCS platform, enabling fully automated, centralized control of process parameters to ensure process stability, increase the level of automation in production, and reduce labor intensity.
In recent years, the Group has placed great emphasis on technological innovation, continuously attracting high-caliber talent, increasing investment in research and development, and prioritizing intellectual property protection. To date, the company has filed more than 110 patent applications. These patent achievements have built up momentum for the company’s future growth, enhanced the technological content of its products, and provided robust scientific and technological support for its sustained development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
Business License
